Federal contract award
75N90025F00021
PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297]
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH - CC |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0170 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $181.2K |
| Current contract value | $181.2K |
| Potential contract value / ceiling | $181.2K |
| Start date | Mar 14, 2025 |
| Current end date | Mar 13, 2026 |
| Potential end date | Mar 13, 2026 |
| Latest award activity | Aug 28, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2025 | P00001 | $-8.3K | MOD P00001 TO REDUCE UNIT PRICE FOR PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297] |
| Mar 14, 2025 | 0 | $189.5K | PIFLUFOLASTAT F-18 INJECTION DRUGS (PYLARIFY) FROM SOFIE CO.:1108959 [25-004297] |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.